Investor Relations

For press releases prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc. (known as Innoviva, Inc. since January 7, 2016), please visit Innoviva, Inc. Investor Relations Press Releases.


Press Releases
Date Title and Summary View
Nov 22, 2016 DUBLIN, Nov. 22, 2016 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) announced today that members of management will participate in a fireside chat at the 28th Annual Piper Jaffra...
Nov 21, 2016 DUBLIN, Nov. 21, 2016 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma") today announced that GlaxoSmithKline plc (GSK) and Innoviva, Inc. (Innoviva) have fil...
Nov 8, 2016 DUBLIN, Nov. 8, 2016 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today reported financial results for the third quarter ended Septembe...
Nov 1, 2016 DUBLIN, Nov. 1, 2016 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today announced that it will release financial results for the period...
Nov 1, 2016 DUBLIN, Nov. 1, 2016 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today announced the presentation of positive new data from several st...
Oct 31, 2016 DUBLIN, Oct. 31, 2016 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today announced the presentation of interim data from the Company's ...
Oct 28, 2016 DUBLIN, Oct. 27, 2016 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today announced the pricing of concurrent underwritten public offeri...
Oct 26, 2016 DUBLIN, Oct. 26, 2016 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today announced that it intends to commence concurrent underwritten ...
Oct 25, 2016 DUBLIN, Oct. 25, 2016 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today announced positive results, including biomarker data, from its...
Oct 20, 2016 DUBLIN and HERTFORDSHIRE, England and PITTSBURGH, Oct. 20, 2016 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma") and Mylan N.V. (NASDAQ, TASE: MYL) ("Mylan"...
1
... NextLast
Add to Briefcase = add release to Briefcase
By clicking on the link below, you will leave www.theravance.com.
CancelContinue
Form content here please :)